Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Safety|August 7, 2012
A pathway to improved prospective observational post-authorization safety studiesVictor A Kiri
BMJ Open|July 27, 2016
Description of an incidence-based model for Assessing comorbidity patterns in disease natural historyVictor A Kiri
Clinical Pharmacology and Therapeutics|May 5, 2026
A Framework for Assessing the Viability of External Control for a Single-Arm TrialVictor A Kiri
Current Drug Safety|May 16, 2009
How real is intention-to-treat (ITT) analysis in non-interventional post authorization safety studies? We can do betterVictor A Kiri, Gilbert MacKenzie
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|September 17, 2009
Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research DatabaseVictor A Kiri, Joan Soriano, George Visick, et al.
Respiratory Medicine|October 24, 2008
Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohortDavid M Mannino, Kourtney J Davis, Victor A Kiri
Respiratory Medicine|June 1, 2005
Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABAVictor A Kiri, Germano Bettoncelli, Renato Testi, et al.
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patientsJoan B Soriano, Victor A Kiri, Neil B Pride, et al.
American Journal of Respiratory and Critical Care Medicine|May 20, 2005
Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time biasVictor A Kiri, Neil B Pride, Joan B Soriano, et al.
Respiratory Medicine|September 17, 2008
Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smokingVictor A Kiri, Leonardo M Fabbri, Kourtney J Davis, et al.
Pageof 2